LabTech(SH:688056) Shang Hai Zheng Quan Bao·2025-08-28 20:14Group 1 - The company has reported a total fundraising amount of RMB 421.6 million from the issuance of 17 million shares at a price of RMB 24.80 per share, with a net amount of RMB 374.48 million after deducting issuance costs [4][5] - As of June 30, 2025, the company has utilized RMB 263.94 million of the raised funds, with a remaining balance of RMB 131.39 million [5][6] - The company has established a management system for the raised funds, including signing tripartite supervision agreements with underwriters and banks to ensure proper usage and storage of the funds [6][7] Group 2 - The company has decided to extend the timeline for certain fundraising investment projects, specifically the "Trace and Ultra-trace Element Analysis ICP-MS and its Online Analysis System Production and R&D Project," from September 2025 to September 2026 [10] - The company has also approved the use of temporarily idle raised funds for cash management, with a maximum of RMB 130 million allocated for safe and liquid investment products [11][12] - The company has utilized RMB 4.3 million of excess raised funds to permanently supplement working capital, representing 28.77% of the total excess funds [11][14] Group 3 - The company has proposed to reappoint the accounting firm Xinyong Zhonghe for the 2025 audit, citing its experience and compliance with auditing standards [19][50] - The board of directors has approved the reappointment, which will be submitted for shareholder approval [26][50] - The company has also reviewed and approved various internal management system revisions to align with regulatory requirements [59][60]